Prevalence and concentration of Aflatoxin M1 in human breast milk in sub-Saharan Africa: a systematic review and meta-analysis, and cancer risk assessment

Int J Environ Health Res. 2023 May;33(5):491-507. doi: 10.1080/09603123.2022.2036330. Epub 2022 Feb 15.

Abstract

This study aimed to assess the prevalence, concentration of AFM1 in human breast milk, and to determine the risk of cancer for infants in sub-Saharan Africa. A systematic literature search was performed using PubMed, CINAHL, Web of science, global health, Cochrane, and Google Scholar electronic databases. A random-effects model was used to estimate the pooled prevalence and concentration of AFM1 in breast milk. The meta-analysis of 8 articles containing 9 studies showed the pooled prevalence of AFM1 in breast milk to be 56.18% (95% CI: 29.65-82.71) and the pooled concentration to be 31.12 ng/L (95% CI: 25.97-36.25). The cancer risk assessment indicated for both male and female 1-month infants in Sierra Leone (HI > 1) is high, and all the rest of the infants are free of risk (HI < 1). The pooled prevalence and mean concentration of AFM1 in breast milk is high. Monitoring of AFB1 concentration of commonly used foods will be of high value in reducing the burden of AFM1.

Keywords: AFM1; Aflatoxin; breast milk; cancer; sub-Saharan Africa.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Aflatoxin M1 / analysis
  • Africa South of the Sahara / epidemiology
  • Female
  • Food Contamination / analysis
  • Humans
  • Infant
  • Male
  • Milk, Human* / chemistry
  • Neoplasms*
  • Prevalence
  • Risk Assessment

Substances

  • Aflatoxin M1